Eli Lilly has a number of lucrative opportunities that should serve as tailwinds for sustained growth. For the past couple of years, two of the biggest themes fueling the stock market to new highs are breakthroughs in the weight loss market and euphoria around artificial intelligence (AI). What if I told you that there's a company that operates across both of these opportunities, and that despite a 61% gain in its share price during the past year, the stock is still a compelling buy? Let's explore what's fu ...